Back to search

Article

Efficacy and safety of sacubitril/valsartan in patients with heart failure with reduced ejection fraction and hypotension

2023-02-22

Abstract excerpt

<title>Abstract</title> <p><bold>Purpose</bold> It is not clear whether sacubitril/valsartan is beneficial for patients with heart failure with reduced ejection fraction (HFrEF) and low systolic blood pressure (SBP). This study aimed to investigate the efficacy and tolerability of sacubitril/valsartan in HFrEF patients with SBP <100 mmHg under real-world conditions. <bold>Methods and results</bold> An observation...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
bc9313e6-3ae8-5ed3-9aae-3e84c9301e66
DOI
10.21203/rs.3.rs-2591328/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Efficacy and safety of sacubitril/valsartan in patients with heart failure with reduced ejection fraction and hypotensionDOI 10.21203/rs.3.rs-2591328/v1
Select a neighboring publication to make it the new centre.